POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
SB 193KANSASSession 2025-2026State BillSigned into law
Enacted

Kansas exempts law enforcement agencies that do not provide emergency opioid antagonists from hiring a physician medical director

Original title: AN ACT concerning the state board of pharmacy; relating to emergency opioid antagonists; exempting law enforcement agencies who do not provide emergency opioid antagonist pursuant to the statewide protocol from the requirement to procure a physician medical director; amending K.S.A. 2024 Supp. 65-16,127 and repealing the existing section.

Last action · April 10, 2025: Enrolled and presented to Governor on Friday, April 4, 2025

Bill progressHistory & official text ↓
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Law enforcement agencies in Kansas that choose not to provide s under the statewide protocol are now exempt from the requirement to hire a . The measure amends existing state pharmacy statutes to remove this administrative obligation for non-participating agencies.

Why it matters

Reduces administrative and staffing requirements for local law enforcement agencies that do not stock or distribute reversal drugs, altering compliance standards under state pharmacy law.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Law Enforcement Agencies

Agencies that do not provide emergency opioid antagonists are relieved of the requirement to procure a physician medical director.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Which law enforcement agencies are exempt from hiring a physician medical director?
Law enforcement agencies that do not provide s pursuant to the statewide protocol are exempt from the requirement.
What happens if a law enforcement agency decides to provide emergency opioid antagonists to its employees?
If an agency elects to provide s dispensed or furnished pursuant to the opioid antagonist protocol, it must procure the services of a physician to serve as medical director.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

Current status: Signed into law.

Procedural history

22 actions
  1. Apr 10, 2025Senate
    Enrolled and presented to Governor on Friday, April 4, 2025
  2. Apr 10, 2025SenateEnrolled
    Approved by Governor on Tuesday, April 8, 2025
  3. Mar 25, 2025Senate
    Concurred with amendments in conference
  4. Mar 13, 2025HouseFloor
    Motion to accede adopted; Representative Carpenter, Representative Bryce, Representative Ruiz, , appointed as conferees
  5. Mar 12, 2025HouseFloor
    Final Action - Passed as amended
  6. Mar 12, 2025Senate
    Nonconcurred with amendments; Conference Committee requested; appointed , and
Show 16 earlier actions
  1. Mar 11, 2025House
    Committee of the Whole - Now working on
  2. Mar 11, 2025HouseFloor
    Committee of the Whole - Committee Report be adopted
  3. Mar 11, 2025HouseFloor
    Committee of the Whole - Be passed as amended
  4. Mar 5, 2025HouseFloor
    Committee Report recommending bill be passed as amended by
  5. Mar 3, 2025House
    Hearing: Monday, March 3, 2025, 1:30 PM — Room 112-N
  6. Feb 25, 2025HouseIntroduced
    Received and Introduced
  7. Feb 25, 2025HouseCommittee
    Referred to House Committee on Health and Human Services
  8. Feb 19, 2025SenateFloor
    Final Action - Substitute passed
  9. Feb 18, 2025Senate
    Committee of the Whole - Now working on
  10. Feb 18, 2025SenateFloor
    Committee of the Whole - Committee Report be adopted recommending substitute bill be passed
  11. Feb 18, 2025SenateFloor
    Committee of the Whole - Substitute bill be passed
  12. Feb 17, 2025SenateFloor
    Committee Report recommending substitute bill be passed by
  13. Feb 12, 2025Senate
    Hearing: Wednesday, February 12, 2025, 8:30 AM — Room 142-S
  14. Feb 12, 2025Senate
    Hearing: Wednesday, February 12, 2025, 8:30 AM — Room Due to inclement weather anticipated, the committee meeting for Feb. 12, 2025 will be via the YouTube Channel."
  15. Feb 5, 2025SenateCommittee
    Referred to Senate Committee on Public Health and Welfare
  16. Feb 4, 2025SenateIntroduced
    Introduced

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Connected Entities

United States Food and Drug Administration, State Board of Pharmacy
OrganizationUnited States Food and Drug Administration“Approves drugs that inhibit the effects of opioids.”Map →
OrganizationState Board of Pharmacy“Issues statewide opioid antagonist protocols and adopts rules and regulations.”Map →

Sources

Open source document

www.kslegislature.gov

Analysis Score

0–100
  • Significance40
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record